The evolving paradigm of cancer trials

Nature Reviews Drug Discovery 17, 225 (2018). doi:10.1038/nrd.2017.210 Author: Shivaani Kummar The development of anticancer therapies is evolving with the advent of novel targeted drugs. In this Comment, I summarize some of the key changes and discuss the various choices for the optimal development of a new generation of cancer therapeutics.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Comment Source Type: research